Literature DB >> 387815

Isolation and characterization of a polyene-resistant variant of Candida tropicalis.

W G Merz, G R Sandford.   

Abstract

An atypical variant of Candida tropicalis was recovered from multiple specimens from a patient who had been a recipient of a bone marrow transplant. This yeast variant showed atypical morphology on corn meal agar distinguishable from typical isolates of C. tropicalis by the production of clusters of blastospores. Isolates of the variant produced acid, but no gas, from maltose and sucrose in fermentation tests. Isolates from blood, pleural fluid, respiratory secretions, and stool specimens were susceptible to amphotericin B and nystatin in an agar dilution system. However, eight isolates of the variant C. tropicalis recovered over a period of 4 weeks from the patient's urine after amphotericin B therapy were found to be resistant to amphotericin B and nystatin. The isolate recovered after 7 days of therapy had minimal inhibitory concentrations of 100 micrograms of amphotericin B and 20 micrograms of nystatin per ml, whereas the seven isolates recovered subsequently had minimal inhibitory concentrations of greater than 500 micrograms of amphotericin B and 50 micrograms of nystatin per ml. The resistant isolates concomitantly lost the capacity to utilize amino acids that susceptible isolates could utilize. Ultraviolet absorption spectra of nonsaponifiable fractions of whole cells showed that resistant isolates lacked ergosterol, which susceptible isolates contained.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 387815      PMCID: PMC275378          DOI: 10.1128/jcm.9.6.677-680.1979

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

1.  Lipid composition and polyene antibiotic resistance of Candida albicans mutants.

Authors:  A M Pierce; H D Pierce; A M Unrau; A C Oehlschlager
Journal:  Can J Biochem       Date:  1978-02

2.  Physiological properties of mutagen-induced variants of Candida albicans resistant to polyene antibiotics.

Authors:  J M Hamilton-Miller
Journal:  J Med Microbiol       Date:  1972-11       Impact factor: 2.472

3.  Resistance to polyene antibiotics and correlated sterol changes in two isolates of Candida tropicalis from a patient with an amphotericin B-resistant funguria.

Authors:  R A Woods; M Bard; I E Jackson; D J Drutz
Journal:  J Infect Dis       Date:  1974-01       Impact factor: 5.226

4.  Non-emergence of polyene-resistant yeasts: an hypothesis.

Authors:  J M Hamilton-Miller
Journal:  Microbios       Date:  1974 Jun-Jul

5.  The development of resistance by candida species to polyene antibiotics in vitro.

Authors:  M A Athar; H I Winner
Journal:  J Med Microbiol       Date:  1971-11       Impact factor: 2.472

6.  Multiplicity of the amino acid permeases in Saccharomyces cerevisiae. IV. Evidence for a general amino acid permease.

Authors:  M Grenson; C Hou; M Crabeel
Journal:  J Bacteriol       Date:  1970-09       Impact factor: 3.490

7.  Sterol content and polyene antibiotic resistance in isolates of Candida krusei, Candida parakrusei, and Candida tropicalis.

Authors:  L M Safe; S H Safe; R E Subden; D C Morris
Journal:  Can J Microbiol       Date:  1977-04       Impact factor: 2.419

8.  Development of amphotericin B-resistant Candida tropicalis in a patient with defective leukocyte function.

Authors:  D J Drutz; R I Lehrer
Journal:  Am J Med Sci       Date:  1978 Jul-Aug       Impact factor: 2.378

  8 in total
  25 in total

1.  Correlation between in vitro susceptibility determined by E test and response to therapy with amphotericin B: results from a multicenter prospective study of candidemia.

Authors:  C J Clancy; M H Nguyen
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

Review 2.  Antifungal susceptibility testing: practical aspects and current challenges.

Authors:  J H Rex; M A Pfaller; T J Walsh; V Chaturvedi; A Espinel-Ingroff; M A Ghannoum; L L Gosey; F C Odds; M G Rinaldi; D J Sheehan; D W Warnock
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

3.  Comparative evaluation of PASCO and national committee for clinical laboratory standards M27-A broth microdilution methods for antifungal drug susceptibility testing of yeasts.

Authors:  B A Arthington-Skaggs; M Motley; D W Warnock; C J Morrison
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

4.  The production of reactive oxygen species is a universal action mechanism of Amphotericin B against pathogenic yeasts and contributes to the fungicidal effect of this drug.

Authors:  Ana Cecilia Mesa-Arango; Nuria Trevijano-Contador; Elvira Román; Ruth Sánchez-Fresneda; Celia Casas; Enrique Herrero; Juan Carlos Argüelles; Jesús Pla; Manuel Cuenca-Estrella; Oscar Zaragoza
Journal:  Antimicrob Agents Chemother       Date:  2014-08-25       Impact factor: 5.191

Review 5.  Amphotericin B: current understanding of mechanisms of action.

Authors:  J Brajtburg; W G Powderly; G S Kobayashi; G Medoff
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

6.  Alternative identification test relying upon sexual reproductive abilities of Candida lusitaniae strains isolated from hospitalized patients.

Authors:  F François; T Noël; R Pépin; A Brulfert; C Chastin; A Favel; J Villard
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

Review 7.  Antifungal susceptibility testing.

Authors:  J H Rex; M A Pfaller; M G Rinaldi; A Polak; J N Galgiani
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

8.  Therapy of fungal infections.

Authors:  D J Drutz
Journal:  Bull N Y Acad Med       Date:  1982-11

9.  Candida lusitaniae causing fatal meningitis.

Authors:  P S Sarma; P Durairaj; A A Padhye
Journal:  Postgrad Med J       Date:  1993-11       Impact factor: 2.401

10.  Strain delineation and epidemiology of Candida (Clavispora) lusitaniae.

Authors:  W G Merz; U Khazan; M A Jabra-Rizk; L C Wu; G J Osterhout; P F Lehmann
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.